Medicare AdvantageAdministrativeMedium impact
MA07.055e, Allergy Immunotherapy
Independence Blue Cross·Allergy & Immunology·Medical Policy
Effective date
Oct 20, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.055e for Allergy Immunotherapy has been updated with changes to general description, guidelines, or informational content. This is a very recent policy change that requires immediate attention from billing teams handling allergy and immunology services.
Action Required
Immediately: Review the updated MA07.055e Allergy Immunotherapy policy at the provided URL to identify specific changes to coverage guidelines, documentation requirements, or billing procedures for Medicare Advantage patients. Compare current billing practices against updated policy requirements and modify workflows as needed.